期刊文献+

S100钙结合蛋白A13和人成纤维细胞生长因子-1在甲状腺肿瘤中的表达及临床意义 被引量:1

S100 calcium binding protein A13 and fibroblast growth factor-1 expression and clinical significance in thyroid tumors
原文传递
导出
摘要 目的 检测S100钙结合蛋白A13(S100A13)和人成纤维细胞生长因子-1(FGF-1)在甲状腺癌、甲状腺腺瘤、正常甲状腺组织中的表达,探讨两者与甲状腺癌发生发展的关系.方法 采用免疫组织化学链霉菌抗生物素蛋白-过氧化物酶(SP)方法检测甲状腺癌、甲状腺腺瘤、正常甲状腺组织中两者的表达,比较两者在两种不同组织中的表达.结果 甲状腺癌组织中,S100A13的表达阳性率为93.3%(56/60),在甲状腺腺瘤组织中S100A13的表达阳性率为66.7% (20/30),在正常甲状腺组织中的表达阳性率为60.0%(12/20),S100A13在甲状腺癌组织的表达阳性率明显高于甲状腺腺瘤及正常甲状腺组织,差异有统计学意义(P<0.05),但是在甲状腺腺瘤及正常甲状腺组织中其表达差异无统计学意义(P>0.05);FGF-1在甲状腺癌组织中的表达阳性率为81.7%(49/60),在甲状腺腺瘤组织中FGF-1的表达阳性率为63.3%(19/30),在正常甲状腺组织中的表达阳性率为55.0%(11/20),FGF-1在甲状腺癌组织的表达阳性率明显高于甲状腺腺瘤及正常甲状腺组织,差异有统计学意义(P<0.05),但是在甲状腺腺瘤及正常甲状腺组织中其表达差异无统计学意义(P>0.05);S100A13与FGF-1表达阳性与甲状腺癌的淋巴结转移相关(P<0.05).结论 S100A13与FGF-1与甲状腺癌的发生及发展密切相关. Objective To detect S100 calcium binding protein A13 (S100A13) and fibroblast growth factor-1 (FGF-1) in thyroid cancer,thyroid adenoma and normal thyroid tissue,and to explore their relationship with the development of thyroid cancer.Methods Streptavidin avidin-peroxidase (SP) immunohistochemical method was used to detect the expression of S100A13 and FGF-1 in thyroid cancer,thyroid adenoma and normal thyroid tissues.Results The expression rate of S100A13 in thyroid cancer,thyroid adenoma and normal thyroid tissues was 93.3% (56/60),66.7% (20/30) and 60.0% (12/20) respectively.The S100A13 expression rate in thyroid cancer and thyroid adenoma tissues was significantly higher than in normal thyroid tissue (P 〈 0.05),but there was no significant difference between thyroid adenoma and normal thyroid tissues (P 〉 0.05).The expression rate of FGF-1 in thyroid cancer,thyroid adenoma and normal thyroid tissues was 81.7% (49/60),63.3% (19/30),and 55.0% (11/20) respectively.The positive rate of FGF-1 expression in thyroid cancer tissues was significantly higher than that in thyroid adenoma and normal thyroid tissues (P 〈 0.05),but there was no significant difference between thyroid adenoma and normal thyroid tissues (P〉 0.05).The positive expression of S100A13 and FGF-1 was associated with lymph node metastasis (P 〈0.05).Conclusion S100A13 and FGF-1 are closely related to the occurrence and development of thyroid cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第2期391-393,共3页 Chinese Journal of Experimental Surgery
关键词 甲状腺癌 甲状腺腺瘤 S100钙结合蛋白A13 人成纤维细胞生长因子-1 Thyroid cancer Thyroid adenoma S100 calcium binding protein A13 Fibro blast growth factor - 1
  • 相关文献

参考文献10

  • 1Makino E, Sakaguchi M, Iwatsuki K,et al. Introduction of an N-termi-nal peptide of S100C/A11 into human cells induces apoptotic celldeath[J]. J Mol Med (Berl) ,2004,82(9) :612-620.
  • 2Eberhardt NL, Grebe SK, Mclver B, et al. The role of the PAX8/PPAR-y fusion oncogene in the pathogenesis of follicular thyroid canc-er[ J]. Mol Cell Endocrinol,2010,321 (1) :50-56.
  • 3徐泱,孙惠川,钦伦秀,刘银坤,樊嘉,汤钊猷.绿色荧光高/低转移人肝癌细胞株MHCC97-HG/LG的建立及鉴定[J].中华实验外科杂志,2006,23(5):531-533. 被引量:3
  • 4Oler G, Camacho CP, Hojaij FC,et al. Gene expression profiling ofpapillary thyroid carcinoma identifies transcripts correlated with BRAFmutational status and lymph node metastasis [ J]. Clin Cancer Res,2008,14(15) :4735 4742.
  • 5Palona I, Namba H, Mitsutake N,et al. BRAFV600E promotes inva-siveness of thyroid cancer cells through nuclear factor kB activation[J]. Endocrinology ,2006,147( 12) :5699-5707.
  • 6Chen PS,Wang MY,Wu SN,et al. CTGF enhances the motility ofbreast cancer cells via an integrin-alphavbeta3-ERKl/2-dependentSI00A4-upregulated pathway [ J ]. J Cell Sci, 2007,120 ( Pi 12 ):2053-2065.
  • 7许昱,陶泽璋,陈谦学,王新春,肖伯奎,华清泉.颞骨胆脂瘤和鳞状细胞癌细胞增殖凋亡的研究[J].中华实验外科杂志,2006,23(5):627-629. 被引量:2
  • 8Maddux NR,Joshi SB,Volkin DB,et al. Multidimensional methods forthe formulation of biopharmaceuticals and vaccines [ J ]. J Pharm Sci,2011,100(10):41714197.
  • 9Dubey VK,Lee J,Somasundaram T,et al. Spackling the crack:stabili-zing human fibroblast growth factor-1 by targeting the N and C termi-nus beta-strand interactions[ J]. J Mol Biol ,2007 ,371 ( 1 ) :256-268.
  • 10Lee J,Blaber SI,Dubey VK,et al. A polypeptide “building block” forthe beta-trefoil fold identified by “ top-down symmetric deconstruc-tion”[J]. J Mol Biol,2011,407(5) :744-763.

二级参考文献17

  • 1Yan Li Zhao-You Tang Sheng-Long Ye Yin-Kun Liu Jie Chen Qiong Xue Jun Chen Dong-Mei Gao Wei-Hua Bao Liver Cancer Institute and Zhongshan Hospital of Fudan University (Former Liver Cancer Institute of Shanghai Medical University),Shanghai 200032,China.Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97[J].World Journal of Gastroenterology,2001,7(5):630-636. 被引量:113
  • 2Zhao-You Tang the Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032, China.Small hepatocellular carcinoma: current status and prospects[J].Hepatobiliary & Pancreatic Diseases International,2002,1(3):349-353. 被引量:7
  • 3Stell P, McCormick MS. Carcinoma of the middle ear: prognostic factors and a suggested staging system.J Laryngol Otol, 1985, 99:847-850.
  • 4Mallet Y, Nouwen J, Lecoete-Houcke M, et al. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1. Laryngoscope, 2003, 113 : 328-331.
  • 5Hassmann-Poznanska E, Skotnicka B, Dzieciol J. Markers of epidermal proliferation in middle ear cholesteatoma. Otolaryngol Pol, 2003, 57:505-511.
  • 6Kojima H, Tanaka Y, Tmamka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg, 1998, 124 : 261-264.
  • 7Apoptosis in normal epithelium, premalignant lesion of the oropharynx and oral cavity: a preliminary study. Oral Oncol Eur J Cancer, 2003,380-383.
  • 8Ergun S, Larlsoo B, Zheng X. Apoptosis in mental skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol, 1999, 24:280.
  • 9Holly A, Sittinger M, Bujia J. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol, 1995, 252: 366-369.
  • 10Shinoda H, Huang CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope, 1995, 105:1232-1237.

共引文献3

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部